FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation

Article metrics

Subjects

Abstract

Mcl-1 (myeloid cell leukemia 1) is a prosurvival member of the Bcl-2 family and plays a critical role in cell survival by suppressing apoptosis through inhibiting the activity of proapoptotic proteins. It has been reported that Mcl-1 is frequently overexpressed in lung cancer. However, the exact molecular mechanism underlying Mcl-1 elevation in lung cancer is largely unknown. Here, we reported that Mcl-1 protein levels inversely correlate with FBXO4 expression, but not other F-box proteins examined, in lung cancer cell lines and lung cancer patient samples. Mechanically, FBXO4 is the E3 ubiquitin ligase to interact with and promote Mcl-1 ubiquitination and degradation. As a result, knockdown of Fbxo4 dramatically elevates Mcl-1 protein levels and increases cell survival and resistance to chemotherapeutic drugs, whereas ectopic expression of FBXO4 displays opposite phenotypes. Therefore, our study suggests that the protein stability of Mcl-1 is governed by FBXO4, which plays an important role in cell survival and chemotherapy for lung cancer.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

References

  1. 1

    Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.

  2. 2

    Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115–132.

  3. 3

    Petersen I, Warth A . Lung cancer: developments, concepts, and specific aspects of the new WHO classification. J Cancer Res Clin Oncol 2016; 142: 895–904.

  4. 4

    Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N . Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2014; 2014: 150845.

  5. 5

    Lowe SW, Lin AW . Apoptosis in cancer. Carcinogenesis 2000; 21: 485–495.

  6. 6

    Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.

  7. 7

    Cory S, Huang DC, Adams JM . The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590–8607.

  8. 8

    Elmore S . Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495–516.

  9. 9

    Hann CL, Daniel VC, Sugar EA, Dobromilskaya I, Murphy SC, Cope L et al. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res 2008; 68: 2321–2328.

  10. 10

    Ramalingam S, Belani CP . Paclitaxel for non-small cell lung cancer. Expert Opin Pharmacother 2004; 5: 1771–1780.

  11. 11

    Perciavalle RM, Opferman JT . Delving deeper: MCL-1's contributions to normal and cancer biology. Trends Cell Biol 2013; 23: 22–29.

  12. 12

    Akgul C . Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 2009; 66: 1326–1336.

  13. 13

    Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA et al. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Br J Cancer 1999; 79: 952–958.

  14. 14

    Wesarg E, Hoffarth S, Wiewrodt R, Kroll M, Biesterfeld S, Huber C et al. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer. Int J Cancer 2007; 121: 2387–2394.

  15. 15

    van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006; 10: 389–399.

  16. 16

    Yecies D, Carlson NE, Deng J, Letai A . Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood 2010; 115: 3304–3313.

  17. 17

    Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR . Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006; 21: 749–760.

  18. 18

    Zhong Q, Gao W, Du F, Wang X . Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121: 1085–1095.

  19. 19

    Ding Q, He X, Hsu JM, Xia W, Chen CT, Li LY et al. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol Cell Biol 2007; 27: 4006–4017.

  20. 20

    Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471: 104–109.

  21. 21

    Vaites LP, Lee EK, Lian Z, Barbash O, Roy D, Wasik M et al. The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation. Mol Cell Biol 2011; 31: 4513–4523.

  22. 22

    Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H et al. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 2008; 14: 68–78.

  23. 23

    Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ et al. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 2006; 24: 355–366.

  24. 24

    Akagi H, Higuchi H, Sumimoto H, Igarashi T, Kabashima A, Mizuguchi H et al. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer 2013; 16: 100–110.

  25. 25

    Wei SH, Dong K, Lin F, Wang X, Li B, Shen JJ et al. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Cancer Chemother Pharmacol 2008; 62: 1055–1064.

  26. 26

    Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471: 110–114.

  27. 27

    Lecker SH, Goldberg AL, Mitch WE . Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 2006; 17: 1807–1819.

  28. 28

    Johnson DE . The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors. Endocr Relat Cancer 2015; 22: T1–17.

  29. 29

    Ciechanover A . Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 2005; 6: 79–87.

  30. 30

    Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE 2008; 3: e1487.

  31. 31

    Deshaies RJ, Joazeiro CA . RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78: 399–434.

  32. 32

    Heo J, Eki R, Abbas T . Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis. Semin Cancer Biol 2016; 36: 33–51.

  33. 33

    Frescas D, Pagano M . Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8: 438–449.

  34. 34

    Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007; 67: 9006–9012.

  35. 35

    Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW . MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993; 90: 3516–3520.

  36. 36

    Thomas LW, Lam C, Edwards SW . Mcl-1; the molecular regulation of protein function. FEBS Lett 2010; 584: 2981–2989.

  37. 37

    Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF et al. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res 2008; 68: 6708–6717.

  38. 38

    Mojsa B, Lassot I, Desagher S . Mcl-1 ubiquitination: unique regulation of an essential survival protein. Cells 2014; 3: 418–437.

  39. 39

    Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010; 463: 103–107.

  40. 40

    Glaser SP, Lee EF, Trounson E, Bouillet P, Wei A, Fairlie WD et al. Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev 2012; 26: 120–125.

Download references

Author information

Correspondence to J Wang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading